|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.70 EUR | +1.19% |
|
-0.38% | -10.40% |
| 12/05 | Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity | RE |
| 12/05 | Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence | DJ |
| Capitalization | 862B 732B 670B 632B 1,179B 82,156B 1,188B 7,947B 3,102B 39,127B 3,235B 3,167B 135,403B | P/E ratio 2026 * |
28.4x | P/E ratio 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise value | 880B 747B 684B 645B 1,202B 83,812B 1,212B 8,108B 3,165B 39,916B 3,301B 3,231B 138,132B | EV / Sales 2026 * |
10.3x | EV / Sales 2027 * | 8.8x |
| Free-Float |
99.82% | Yield 2026 * |
0.7% | Yield 2027 * | 0.78% |
Last Transcript: Eli Lilly and Company
| 1 day | +1.19% | ||
| 1 week | -0.38% | ||
| Current month | +2.54% | ||
| 1 month | +2.31% | ||
| 3 months | -3.79% | ||
| 6 months | -4.07% | ||
| Current year | -10.40% |
| 1 week | 804.4 |  | 845.8 |
| 1 month | 728.9 | | 845.8 |
| Current year | 728.9 | | 968.1 |
| 1 year | 537.4 | | 968.1 |
| 3 years | 387.4 | | 968.1 |
| 5 years | 158.2 | | 968.1 |
| 10 years | 59 | | 968.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 70 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | -0.38% | - | - | 846B | |
| +0.05% | -1.24% | +43.58% | +37.54% | 533B | |
| +0.61% | -2.58% | +9.85% | +38.33% | 356B | |
| -0.94% | -0.38% | +22.40% | +11.63% | 324B | |
| +1.18% | -0.07% | +31.86% | +13.23% | 282B | |
| +0.30% | -0.12% | +25.07% | +22.81% | 278B | |
| -0.09% | -1.62% | +46.48% | -5.33% | 275B | |
| +3.34% | +6.03% | -32.48% | -48.08% | 203B | |
| -0.64% | +1.77% | +23.97% | +41.89% | 179B | |
| +1.67% | +0.63% | +37.78% | +69.66% | 163B | |
| Average | +0.67% | -0.42% | +23.17% | +20.19% | 288.07B | |
| Weighted average by Cap. | +0.63% | -0.97% | +25.68% | +21.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.15B 72.26B 66.17B 62.39B 116B 8,112B 117B 785B 306B 3,864B 319B 313B 13,370B | 97.62B 82.84B 75.87B 71.53B 133B 9,301B 134B 900B 351B 4,430B 366B 359B 15,329B |
| Net income | 30.99B 26.3B 24.08B 22.71B 42.35B 2,952B 42.69B 286B 111B 1,406B 116B 114B 4,866B | 37.83B 32.11B 29.4B 27.72B 51.71B 3,605B 52.12B 349B 136B 1,717B 142B 139B 5,941B |
| Net Debt | 17.38B 14.75B 13.51B 12.74B 23.76B 1,656B 23.95B 160B 62.53B 789B 65.22B 63.85B 2,729B | -3.07B -2.61B -2.39B -2.25B -4.2B -293B -4.23B -28.33B -11.06B -139B -11.53B -11.29B -483B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/05/26 | 827.00 € | +1.72% | 426 |
| 08/05/26 | 813.00 € | -2.44% | 351 |
| 07/05/26 | 833.30 € | -1.28% | 218 |
| 06/05/26 | 844.10 € | +0.63% | 279 |
| 05/05/26 | 838.80 € | +1.57% | 185 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition